METHOD FOR PERITONEAL REMOVAL OF ELECTROLYTES AND INFLAMMATORY MEDIATORS
A method of peritoneal removal of electrolytes and inflammatory mediators. The method begins with infusing a treatment solution into the peritoneal cavity of a patient by way of a catheter. The treatment solution is drained from the peritoneal cavity by way of the catheter. During the draining, the treatment solution is filtered for removing electrolytes and inflammatory mediators.
1 . A method of peritoneal removal of electrolytes and inflammatory mediators, the method comprising:
infusing a treatment solution into the peritoneal cavity of a patient by way of a catheter;
draining, by way of the catheter, the treatment solution from the peritoneal cavity; and
filtering electrolytes and inflammatory mediators from the treatment solution while the treatment solution is draining.
2 . The method of claim 1 , wherein filtering electrolytes and inflammatory mediators further comprises:
positioning a filter in fluid communication with the catheter, the filter comprising:
a proximal end;
a distal end;
a lumen extending between the proximal and distal ends; and
a filler within the lumen of the filter, the filler configured to remove electrolytes, inflammatory mediators, or both by size exclusion.
3 . The method of claim 2 , wherein the filler is selected from the group consisting of:
a polymer, a resin, or diffusion tubes configured to remove inflammatory mediators.
4 . The method of claim 2 , the filler comprising a binding agent configured to selectively bind electrolytes, inflammatory mediators, or both.
5 . The method of claim 4 , wherein the binding agent is selected from the group consisting of:
a polymer, a resin, or diffusion tubes configured to remove inflammatory mediators.
6 . The method of claim 1 , wherein infusing the treatment solution further comprises:
a treatment solution container fluidically coupled to a distal end of the catheter, the treatment solution container configured to support the treatment solution.
7 . The method of claim 6 , wherein infusing the treatment solution further comprises:
elevating the treatment solution container above an infusion site of the patient.
8 . The method of claim 6 , wherein draining the treatment solution further comprises:
lowering the treatment solution container below an infusion site of the patient.
9 . The method of claim 6 , further comprising:
elevating the treatment solution container above an infusion site of the patient for infusing the treatment solution; and
lowering the treatment solution container below the infusion site for draining the treatment solution.
10 . The method of claim 1 , wherein the treatment solution comprises:
saline; and
a binding agent configured to selectively bind electrolytes, inflammatory mediators, or both.
11 . A method of peritoneal removal of electrolytes and inflammatory mediators, the method comprising:
elevating a treatment solution container above an infusion site of the patient;
while elevating, infusing a treatment solution from the treatment solution into the peritoneal cavity of the patient by way of a catheter;
lowering the treatment solution container below the infusion site for draining the treatment solution;
while lowering, draining, by way of the catheter, the treatment solution from the peritoneal cavity; and
filtering electrolytes and inflammatory mediators from the treatment solution during the infusing, during the draining, or both.
12 . The method of claim 11 , wherein filtering electrolytes and inflammatory mediators further comprises:
positioning a filter in fluid communication with the catheter, the filter comprising:
a proximal end;
a distal end;
a lumen extending between the proximal and distal ends; and
a filler within the lumen of the filter, the filler configured to remove electrolytes, inflammatory mediators, or both.
13 . The method of claim 12 , wherein the filler is selected from the group consisting of:
a polymer, a resin, or diffusion tubes configured to remove inflammatory mediators.
14 . The method of claim 11 , wherein filtering electrolytes and inflammatory mediators further comprises:
positioning a filter in fluid communication with the catheter, the filter comprising:
a proximal end;
a distal end;
a lumen extending between the proximal and distal ends; and
a filler within the lumen of the filter, the filler comprising a binding agent configured to selectively bind electrolytes, inflammatory mediators, or both.
15 . The method of claim 14 , wherein the binding agent is selected from the group consisting of:
a polymer, a resin, or diffusion tubes configured to remove inflammatory mediators.
16 . The method of claim 11 , wherein the treatment solution comprises:
saline; and
a binding agent configured to selectively bind electrolytes, inflammatory mediators, or both.
17 . The method of claim 11 , further comprising:
re-instilling the treatment solution by, again, elevating the treatment solution container above the infusion site.
18 . The method of claim 17 , further comprising:
again draining the treatment solution by again lowering the treatment solution container to below the infusion site.
19 . A method of peritoneal removal of electrolytes and inflammatory mediators, the method comprising:
implanting a filter cartridge in the peritoneal cavity of a patient;
infusing a treatment solution into the peritoneal cavity of a patient; and
drawing the treatment solution from the peritoneal cavity through the filter cartridge;
wherein the filter cartridge comprises a binding agent enclosed within a porous surgical packing material.
20 . The method of claim 19 , wherein drawing the treatment solution further comprises:
pulling the treatment solution from the peritoneal cavity by way of a would drain.
21 . The method of claim 20 , wherein the wound drain is fluidically coupled to a pump.
22 . The method of claim 19 , further comprising:
re-instilling the treatment solution into the peritoneal cavity.
23 . The method of claim 19 , wherein the binding agent is configured to selectively bind electrolytes, inflammatory mediators, or both.
24 . The method of claim 23 , wherein the binding agent is selected from the group consisting of:
a polymer, a resin, or diffusion tubes configured to remove inflammatory mediators.